An Efficacy, Safety, and Tolerability Study of Canagliflozin (JNJ-28431754) in Patients With Type 2 Diabetes

Clinical trial NCT00642278 · COMPLETED

Trial details

NCT number: NCT00642278
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus, Type II Diabetes Mellitus, Non Insulin Dependent

Start date: 2008-04-01
Primary completion: 2009-01-01
Enrollment: 451

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.